Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) EPS (Weighted Average and Diluted) (2022 - 2025)

Historic EPS (Weighted Average and Diluted) for Dna X (SONM) over the last 4 years, with Q3 2025 value amounting to -$4.83.

  • Dna X's EPS (Weighted Average and Diluted) rose 4817.6% to -$4.83 in Q3 2025 from the same period last year, while for Sep 2025 it was $33.83, marking a year-over-year increase of 38939.26%. This contributed to the annual value of -$7.27 for FY2024, which is 3624270.36% down from last year.
  • As of Q3 2025, Dna X's EPS (Weighted Average and Diluted) stood at -$4.83, which was up 4817.6% from -$0.79 recorded in Q2 2025.
  • Over the past 5 years, Dna X's EPS (Weighted Average and Diluted) peaked at $0.12 during Q3 2023, and registered a low of -$9.32 during Q3 2024.
  • In the last 4 years, Dna X's EPS (Weighted Average and Diluted) had a median value of -$0.31 in 2023 and averaged -$1.49.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 40000.0% in 2023, then plummeted by 786666.67% in 2024.
  • Quarter analysis of 4 years shows Dna X's EPS (Weighted Average and Diluted) stood at -$0.04 in 2022, then plummeted by 655.75% to -$0.31 in 2023, then tumbled by 1421.92% to -$4.72 in 2024, then dropped by 2.37% to -$4.83 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$4.83 for Q3 2025, versus -$0.79 for Q2 2025 and $0.08 for Q1 2025.